COHANCE
Invest with MTF
Invest Now
Invest in Cohance Lifesciences with 2.86X leverage
Performance
- Low
- ₹304
- High
- ₹318
- 52 Week Low
- ₹303
- 52 Week High
- ₹1,328
- Open Price₹315
- Previous Close₹315
- Volume1,073,615
- 50 DMA₹431.64
- 100 DMA₹553.72
- 200 DMA₹708.75
Investment Returns
- Over 1 Month -23.57%
- Over 3 Month -47.51%
- Over 6 Month -65.87%
- Over 1 Year -74.79%
Smart Investing Starts Here Start SIP with Cohance Lifesciences for Steady Growth!
Cohance Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 57.9
- PEG Ratio
- -2.1
- Market Cap Cr
- 11,684
- P/B Ratio
- 3.1
- Average True Range
- 19.21
- EPS
- 7.86
- Dividend Yield
- 0
- MACD Signal
- -36.76
- RSI
- 24.81
- MFI
- 46.81
Cohance Lifesciences Financials
Cohance Lifesciences Technicals
EMA & SMA
Current Price
₹305.40
-9.7
(-3.08%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹351.81
- 50 Day
- ₹431.64
- 100 Day
- ₹553.72
- 200 Day
- ₹708.75
Resistance and Support
309.05
- R3 327.40
- R2 322.50
- R1 313.95
- S1 300.50
- S2 295.60
- S3 287.05
Cohance Lifesciences Corporate Actions - Bonus, Splits, Dividends
Cohance Lifesciences F&O
About Cohance Lifesciences
- NSE Symbol
- COHANCE
- BSE Symbol
- 543064
- Managing Director
- Dr. V Prasada Raju
- ISIN
- INE03QK01018
Similar Stocks to Cohance Lifesciences
Cohance Lifesciences FAQs
Cohance Lifesciences share price is ₹305 As on 21 February, 2026 | 16:41
The Market Cap of Cohance Lifesciences is ₹11683.6 Cr As on 21 February, 2026 | 16:41
The P/E ratio of Cohance Lifesciences is 57.9 As on 21 February, 2026 | 16:41
The PB ratio of Cohance Lifesciences is 3.1 As on 21 February, 2026 | 16:41
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.